Cargando…
Noninitiation of Discharge Medications After Revascularization
BACKGROUND: Timely initiation of medication therapy after a cardiovascular event is vital to achieve optimal patient outcomes, yet there is a lack of insight on the frequency and predictors of discharge medications that are delayed or never initiated. OBJECTIVES: To (a) describe how frequently patie...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390938/ https://www.ncbi.nlm.nih.gov/pubmed/32105182 http://dx.doi.org/10.18553/jmcp.2020.26.3.305 |
_version_ | 1785082587888222208 |
---|---|
author | Medaglio, Dominique Glasgow, Justin Zhang, Zugui Elliott, Daniel |
author_facet | Medaglio, Dominique Glasgow, Justin Zhang, Zugui Elliott, Daniel |
author_sort | Medaglio, Dominique |
collection | PubMed |
description | BACKGROUND: Timely initiation of medication therapy after a cardiovascular event is vital to achieve optimal patient outcomes, yet there is a lack of insight on the frequency and predictors of discharge medications that are delayed or never initiated. OBJECTIVES: To (a) describe how frequently patients do not fill newly prescribed discharge medications within 30 days after revascularization and (b) identify predictors of patients who did not fill their new medications. METHODS: A single-center, retrospective analysis was conducted of patients discharged after percutaneous coronary intervention or coronary artery bypass grafting. Discharge prescriptions were linked to pharmacy claims data to identify medications that were not filled within 30 days of discharge. RESULTS: 1,206 patients and their 5,253 discharge medications were included for study. More than one third of patients did not fill at least 1 discharge medication within 30 days (466/1,206, 38.6%); nearly 1 in 10 (116/1,206, 9.6%) did not fill any of their discharge prescriptions. Significant predictors of nonadherence included longer length of stay and higher number of prescribed discharge medications (both P values < 0.05). The largest classes of unfilled medications included insulin, factor Xa inhibitors, and narcotic analgesics. CONCLUSIONS: Noninitiation is a common issue among patients after cardiac revascularization. These patients may be at a higher risk of not filling their medications if they experience longer lengths of stay or are prescribed a higher number of medications at discharge. |
format | Online Article Text |
id | pubmed-10390938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103909382023-08-02 Noninitiation of Discharge Medications After Revascularization Medaglio, Dominique Glasgow, Justin Zhang, Zugui Elliott, Daniel J Manag Care Spec Pharm Research Brief BACKGROUND: Timely initiation of medication therapy after a cardiovascular event is vital to achieve optimal patient outcomes, yet there is a lack of insight on the frequency and predictors of discharge medications that are delayed or never initiated. OBJECTIVES: To (a) describe how frequently patients do not fill newly prescribed discharge medications within 30 days after revascularization and (b) identify predictors of patients who did not fill their new medications. METHODS: A single-center, retrospective analysis was conducted of patients discharged after percutaneous coronary intervention or coronary artery bypass grafting. Discharge prescriptions were linked to pharmacy claims data to identify medications that were not filled within 30 days of discharge. RESULTS: 1,206 patients and their 5,253 discharge medications were included for study. More than one third of patients did not fill at least 1 discharge medication within 30 days (466/1,206, 38.6%); nearly 1 in 10 (116/1,206, 9.6%) did not fill any of their discharge prescriptions. Significant predictors of nonadherence included longer length of stay and higher number of prescribed discharge medications (both P values < 0.05). The largest classes of unfilled medications included insulin, factor Xa inhibitors, and narcotic analgesics. CONCLUSIONS: Noninitiation is a common issue among patients after cardiac revascularization. These patients may be at a higher risk of not filling their medications if they experience longer lengths of stay or are prescribed a higher number of medications at discharge. Academy of Managed Care Pharmacy 2020-03 /pmc/articles/PMC10390938/ /pubmed/32105182 http://dx.doi.org/10.18553/jmcp.2020.26.3.305 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Brief Medaglio, Dominique Glasgow, Justin Zhang, Zugui Elliott, Daniel Noninitiation of Discharge Medications After Revascularization |
title | Noninitiation of Discharge Medications After Revascularization |
title_full | Noninitiation of Discharge Medications After Revascularization |
title_fullStr | Noninitiation of Discharge Medications After Revascularization |
title_full_unstemmed | Noninitiation of Discharge Medications After Revascularization |
title_short | Noninitiation of Discharge Medications After Revascularization |
title_sort | noninitiation of discharge medications after revascularization |
topic | Research Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390938/ https://www.ncbi.nlm.nih.gov/pubmed/32105182 http://dx.doi.org/10.18553/jmcp.2020.26.3.305 |
work_keys_str_mv | AT medagliodominique noninitiationofdischargemedicationsafterrevascularization AT glasgowjustin noninitiationofdischargemedicationsafterrevascularization AT zhangzugui noninitiationofdischargemedicationsafterrevascularization AT elliottdaniel noninitiationofdischargemedicationsafterrevascularization |